ArticleCancer discovery2018
Plasma-Based Genotyping Pays Off in NSCLC.
Article in Cancer discovery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Comment on
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A recent study showed that plasma-based genotyping of circulating tumor DNA from patients with metastatic non-small cell lung cancer detected clinically relevant targetable driver and resistance mutations in roughly one third of cases, whether used alone or in combination with sequencing data from tumor tissue. This means that liquid biopsies are a valid clinical option for many patients. In addition, more than 85% of patients who received targeted treatment based on the liquid biopsy findings experienced a complete or partial response or stable disease.
Indexed as
Identifiers
30377169What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.